KROS

Keros Therapeutics, Inc. - common stock (KROS)

About Keros Therapeutics, Inc. - common stock (KROS)

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Details

Daily high

$11.60

Daily low

$11.08

Price at open

$11.31

52 Week High

$22.55

52 Week Low

$9.69

Market cap

221.9M

Dividend yield

Volume

120,719

Avg. volume

184,330

P/E ratio

-3.02

Keros Therapeutics, Inc. - common stock News